View in EDS HTML Full Text PDF Full Text

Stellate ganglion block to mitigate thalamic pain syndrome of an oncological origin.

Saved in:
Bibliographic Details
Title: Stellate ganglion block to mitigate thalamic pain syndrome of an oncological origin.
Authors: Wilkinson, Alex J., Yang, Ajax, Chen, Grant H.
Source: Pain Practice. Jan2024, Vol. 24 Issue 1, p231-234. 4p.
Subjects: Cancer pain, Drug efficacy, Chronic pain, Autonomic ganglia, Cancer patient psychology, Neuralgia, Nerve block, Magnetic resonance imaging, Thalamus diseases, Arm, Brain tumors, Ganglionic blocking agents, Headache, Facial neuralgia, Pain management, Disease complications, Evaluation
Abstract: Background: Thalamic pain syndrome (TPS) is an enigmatic and rare condition. Thalamic pain syndrome is under the umbrella of central pain syndrome, which is classically associated with multiple sclerosis, spinal cord injury, postamputation, epilepsy, stroke, tumor, and Parkinson's disease. The mainstay treatment of TPS is polypharmacy. There is uncertainty about the intermediate options to manage medication‐resistant TPS before resorting to invasive, and often expensive, intracranial therapies. Stellate ganglion block (SGB) has shown promise in reducing TPS symptoms of the upper extremity and face following a thalamic ischemic event. Aims: Discuss the effect and potential utility of SGB on ipsilateral headache, facial, and upper extremity neuropathic pain due to thalamic malignancies. Materials and Methods: A review of two patient records that underwent SGB for treatment of TPS of oncologic origin. Results: We present two cases of the successful use of SGB for the treatment of oncologic‐related TPS for patients who had failed other conservative pharmacologic measures. Discussion: Chronic pain is a complex experience that often simultaneously involves psychosocial, neuropathic, and nociceptive constituents. Among advanced cancer patients, factors such as an individual's spirituality, psychological stressors, and views on their mortality add layers of intricacy in addressing their pain. While TPS has been characterized in both stroke populations and oncologic populations, the treatment of SGB for pain relief in TPS has been limited to the stroke population. Repeated SGB worked to alleviate the ipsilateral headache, facial, and upper extremity pain in these two patients. The benefits of utilization of SGB, with the possibility of pain relief, within the thalamic malignancy population cannot be understated. Conclusion: In summary, ultrasound‐guided SGB may be considered in patients with TPS due to thalamic cancer, before pursuing more invasive intracranial surgeries to treat pain. [ABSTRACT FROM AUTHOR]
Copyright of Pain Practice is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 174634721
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Stellate ganglion block to mitigate thalamic pain syndrome of an oncological origin.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Wilkinson%2C+Alex+J%2E%22">Wilkinson, Alex J.</searchLink><br /><searchLink fieldCode="AR" term="%22Yang%2C+Ajax%22">Yang, Ajax</searchLink><br /><searchLink fieldCode="AR" term="%22Chen%2C+Grant+H%2E%22">Chen, Grant H.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Pain+Practice%22">Pain Practice</searchLink>. Jan2024, Vol. 24 Issue 1, p231-234. 4p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Cancer+pain%22">Cancer pain</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+efficacy%22">Drug efficacy</searchLink><br /><searchLink fieldCode="DE" term="%22Chronic+pain%22">Chronic pain</searchLink><br /><searchLink fieldCode="DE" term="%22Autonomic+ganglia%22">Autonomic ganglia</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+patient+psychology%22">Cancer patient psychology</searchLink><br /><searchLink fieldCode="DE" term="%22Neuralgia%22">Neuralgia</searchLink><br /><searchLink fieldCode="DE" term="%22Nerve+block%22">Nerve block</searchLink><br /><searchLink fieldCode="DE" term="%22Magnetic+resonance+imaging%22">Magnetic resonance imaging</searchLink><br /><searchLink fieldCode="DE" term="%22Thalamus+diseases%22">Thalamus diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Arm%22">Arm</searchLink><br /><searchLink fieldCode="DE" term="%22Brain+tumors%22">Brain tumors</searchLink><br /><searchLink fieldCode="DE" term="%22Ganglionic+blocking+agents%22">Ganglionic blocking agents</searchLink><br /><searchLink fieldCode="DE" term="%22Headache%22">Headache</searchLink><br /><searchLink fieldCode="DE" term="%22Facial+neuralgia%22">Facial neuralgia</searchLink><br /><searchLink fieldCode="DE" term="%22Pain+management%22">Pain management</searchLink><br /><searchLink fieldCode="DE" term="%22Disease+complications%22">Disease complications</searchLink><br /><searchLink fieldCode="DE" term="%22Evaluation%22">Evaluation</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background: Thalamic pain syndrome (TPS) is an enigmatic and rare condition. Thalamic pain syndrome is under the umbrella of central pain syndrome, which is classically associated with multiple sclerosis, spinal cord injury, postamputation, epilepsy, stroke, tumor, and Parkinson's disease. The mainstay treatment of TPS is polypharmacy. There is uncertainty about the intermediate options to manage medication‐resistant TPS before resorting to invasive, and often expensive, intracranial therapies. Stellate ganglion block (SGB) has shown promise in reducing TPS symptoms of the upper extremity and face following a thalamic ischemic event. Aims: Discuss the effect and potential utility of SGB on ipsilateral headache, facial, and upper extremity neuropathic pain due to thalamic malignancies. Materials and Methods: A review of two patient records that underwent SGB for treatment of TPS of oncologic origin. Results: We present two cases of the successful use of SGB for the treatment of oncologic‐related TPS for patients who had failed other conservative pharmacologic measures. Discussion: Chronic pain is a complex experience that often simultaneously involves psychosocial, neuropathic, and nociceptive constituents. Among advanced cancer patients, factors such as an individual's spirituality, psychological stressors, and views on their mortality add layers of intricacy in addressing their pain. While TPS has been characterized in both stroke populations and oncologic populations, the treatment of SGB for pain relief in TPS has been limited to the stroke population. Repeated SGB worked to alleviate the ipsilateral headache, facial, and upper extremity pain in these two patients. The benefits of utilization of SGB, with the possibility of pain relief, within the thalamic malignancy population cannot be understated. Conclusion: In summary, ultrasound‐guided SGB may be considered in patients with TPS due to thalamic cancer, before pursuing more invasive intracranial surgeries to treat pain. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Pain Practice is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=174634721
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/papr.13275
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 4
        StartPage: 231
    Subjects:
      – SubjectFull: Cancer pain
        Type: general
      – SubjectFull: Drug efficacy
        Type: general
      – SubjectFull: Chronic pain
        Type: general
      – SubjectFull: Autonomic ganglia
        Type: general
      – SubjectFull: Cancer patient psychology
        Type: general
      – SubjectFull: Neuralgia
        Type: general
      – SubjectFull: Nerve block
        Type: general
      – SubjectFull: Magnetic resonance imaging
        Type: general
      – SubjectFull: Thalamus diseases
        Type: general
      – SubjectFull: Arm
        Type: general
      – SubjectFull: Brain tumors
        Type: general
      – SubjectFull: Ganglionic blocking agents
        Type: general
      – SubjectFull: Headache
        Type: general
      – SubjectFull: Facial neuralgia
        Type: general
      – SubjectFull: Pain management
        Type: general
      – SubjectFull: Disease complications
        Type: general
      – SubjectFull: Evaluation
        Type: general
    Titles:
      – TitleFull: Stellate ganglion block to mitigate thalamic pain syndrome of an oncological origin.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wilkinson, Alex J.
      – PersonEntity:
          Name:
            NameFull: Yang, Ajax
      – PersonEntity:
          Name:
            NameFull: Chen, Grant H.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: Jan2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 15307085
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Pain Practice
              Type: main
ResultId 1